COCP
Cocrystal Pharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.16M
P/E Ratio
—
EPS
$-0.78
Beta
1.18
52W High
$2.19
52W Low
$0.86
50-Day MA
$1.19
200-Day MA
$1.22
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Cocrystal Pharma Inc
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.
Fundamentals
| Revenue (TTM) | 510,000 |
| Gross Profit (TTM) | $-5.05M |
| EBITDA | $-8.95M |
| Operating Margin | 0.00% |
| Return on Equity | -111.40% |
| Return on Assets | -48.70% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $0.46 |
| Price-to-Book | 3.03 |
| Price-to-Sales (TTM) | 92.45 |
| EV/Revenue | 0.71 |
| EV/EBITDA | 0.66 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 26.90% |
| Shares Outstanding | $13.79M |
| Float | $9.12M |
| % Insiders | 25.45% |
| % Institutions | 5.57% |
Historical Volatility
HV 10-Day
50.70%
HV 20-Day
163.17%
HV 30-Day
136.73%
HV 60-Day
105.33%
HV Rank
97.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($8.00 target)
2
BuyData last updated: 4/29/2026